Predicting the change in breast cancer deaths in spain by 2019: A bayesian approach

Epidemiology

Volumn 24, Issue 3, 2013, Pages 454-460

  Clèries, Ramon ^a,b   Martínez, Jose Miguel ^c   Moreno, Victor ^b,d   Yasui, Yutaka ^e   Ribes, Josepa ^a,b   Borràs, Josep Maria ^a,b  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BAYES THEOREM; BREAST CANCER; CANCER MORTALITY; DEMOGRAPHY; FEMALE; GROUPS BY AGE; HUMAN; MATHEMATICAL MODEL; POPULATION; POPULATION SIZE; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; SPAIN;

ADULT; AGED; AGED, 80 AND OVER; BAYES THEOREM; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FORECASTING; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; SPAIN;

EID: 84876297023     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e31828b0866     Document Type: Article

References (47)

1. Bosetti C, Bertuccio P, Levi F, Chatenoud L, Negri E, La Vecchia C. The decline in breast cancer mortality in europe: an update (to 2009). Breast. 2012;21:77-82.
2. Correa C, Mcgale P, Taylor P, Wang Y, Clarke M, Davies C. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010:162-167.
3. Berry DA, Cronin KA, Plevritis SK, et al; Cancer intervention and Surveillance Modeling network (ciSnet) collaborators. effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784-1792.
4. Clèries R, Ribes J, Esteban L, Martinez JM, Borràs JM. Time trends of breast cancer mortality in Spain during the period 1977-2001 and Bayesian approach for projections during 2002-2016. Ann Oncol. 2006;17:1783-1791.
5. Pollán M, Michelena MJ, Ardanaz E, Izquierdo A, Sánchez-Pérez MJ, Torrella A; Breast cancer Working group. Breast cancer incidence in Spain before, during and after the implementation of screening programmes. Ann Oncol. 2010;21(suppl 3):iii97-iii102.
6. Cleries R, Martínez JM, Valls J, et al. Life expectancy and age-period-cohort effects: analysis and projections of mortality in Spain between 1977 and 2016. Public Health. 2009;123:156-162.
7. Instituto nacional de estadistica (ine). long-term projection of Spanish Population 2009-2049. available at: http://www.ine.es/metodologia/t20/t2030251. pdf. accessed 10 December 2012.
8. Willekens FJ, Drewe P. A multiregional model for regional demographic projection. in: Heide H, Willekens FJ, Eds. Demographic Research and Spatial Policy. london: academic Press; 1984:309-334.
9. Clayton D, Schiffers E. Models for temporal variation in cancer rates. i: age-period and age-cohort models. Stat Med. 1987;6:449-467.
10. Clayton D, Schiffers E. Models for temporal variation in cancer rates. ii: age-period-cohort models. Stat Med. 1987;6:469-481.
11. Bashir SA, Estève J. Projecting cancer incidence and mortality using Bayesian age-period-cohort models. J Epidemiol Biostat. 2001;6:287-296.
12. Knorr-Held L, Rainer E. Projections of lung cancer mortality in West germany: a case study in Bayesian prediction. Biostatistics. 2001;2:109-129.
13. Bray I. Application of Markov chain Monte carlo methods to projecting cancer incidence and mortality. Appl Stat. 2002;51:151-164.
14. Schmid V, Held L. Bayesian extrapolation of space-time trends in cancer registry data. Biometrics. 2004;60:1034-1042.
15. Plummer M, Clayton D. Measurement error in dietary assessment: an investigation using covariance structure models. Part i. Stat Med. 1993;12:925-935.
16. Berzuini C, Clayton D. Bayesian analysis of survival on multiple time scales. Stat Med. 1994;13:823-838.
17. Fong Y, Rue H, Wakefeld J. Bayesian inference for generalized linear mixed models. Biostatistics. 2010;11:397-412.
18. Baker A, Bray I. Bayesian projections: what are the effects of excluding data from younger age groups? Am J Epidemiol. 2005; 162: 798-805.
19. Spiegelhalter DJ, Best NG, Carlin B P, Van der linde AJ. Bayesian measures of model complexity and ft (with discussion). J Roy Stat Soc. 2002;64:583-639.
20. Møller B, Fekjaer H, Hakulinen T, et al. Prediction of cancer incidence in the nordic countries: empirical comparison of different approaches. Stat Med. 2003;22:2751-2766.
21. Gelman A, Carlin JB, Stern H, Rubin DB. Bayesian Data analysis. 2nd ED. london: chapman & Hall; 2003.
22. Clèries R, Ribes J, Buxo M, et al. Bayesian approach to predicting cancer incidence for an area without cancer registration by using cancer incidence data from nearby areas. Stat Med. 2012;31:978-987.
23. Rue H, Martino S, Chopin N. approximate Bayesian inference for latent gaussian models by using integrated nested laplace approximations (with discussion). J Roy Stat Soc. 2009;71:319-392.
24. Bashir S, Estève J. analysing the difference due to risk and demographic factors for incidence or mortality. Int J Epidemiol. 2000;29:878-884.
25. Valls J, Clèries R, Gálvez J, et al. riskDiff: a web tool for the analysis of the difference due to risk and demographic factors for incidence or mortality data. BMC Public Health. 2009;9:473.
26. Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale g. Breast cancer. Lancet. 2005;365:1727-1741.
27. Benach J, Yasui Y, Martínez JM, Borrell C, Pasarín MI, Daponte A. The geography of the highest mortality areas in Spain: a striking cluster in the southwestern region of the country. Occup Environ Med. 2004;61:280-281.
28. Izquierdo A, González JR, Moreno V, et al. Time trend of breast cancer incidence in catalonia. Med Clin (Barc). 2006;126:286-289.
29. Bray F, Møller B. Predicting the future burden of cancer. Nat Rev Cancer. 2006;6:63-74.
30. Hendrick RE, Klabunde C, Grivegnee A, Pou G, Ballard-Barbash R. Technical quality control practices in mammography screening programs in 22 countries. Int J Qual Health Care. 2002;14:219-226.
31. Botha JL, Bray F, Sankila R, Parkin DM. Breast cancer incidence and mortality trends in 16 european countries. Eur J Cancer. 2003;39:1718-1729.
32. Hébert-croteau N, Brisson J, Latreille J, Rivard M, Abdelaziz N, Martin G. Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer. J Clin Oncol. 2004;22:3685-3693.
33. Jatoi I, Miller AB. Why is breast-cancer mortality declining? Lancet Oncol. 2003;4:251-254.
34. Clarke M, Collins R, Darby S, et al; Early Breast cancer trialists' collaborative group (eBctcg). effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087-2106.
35. Dowsett M, Cuzick J, Ingle J, et al. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol. 2010;28:509-518.
36. Cuzick J, Decensi A, Arun B, et al. Preventive therapy for breast cancer: a consensus statement. Lancet Oncol. 2011;12:496-503.
37. Brenner H, Francisci S, De angelis R, et al. Long-term survival expectations of cancer patients in europe in 2000-2002. Eur J Cancer. 2009;45:1028-1041.
38. Hutchinson L. Screening: reduced breast cancer mortality rates in europe are not due to screening. Nat Rev Clin Oncol. 2011;8:570.
39. Martinez-alonso M, Vilaprinyo E, Marcos-gragera R, Rue M. Breast cancer incidence and overdiagnosis in catalonia (Spain). Breast Cancer Res. 2010;12:r58.
40. Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ. 2005;83:171-177.
41. Tarone RE, Chu KC. Age-period-cohort analyses of breast-, ovarian-, en-dometrial-and cervical-cancer mortality rates for caucasian women in the USa. J Epidemiol Biostat. 2000;5:221-231.
42. La Vecchia C, Negri E, Levi F, Decarli A. Age, cohort-of-birth, and pe-riod-of-death trends in breast cancer mortality in europe. J Natl Cancer Inst. 1997;89:732-734.
43. Kumle M. Declining breast cancer incidence and decreased Hrt use. Lancet. 2008;372:608-610.
44. Chlebowski RT, Kuller LH, Prentice RL, et al; WHi investigators. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med. 2009;360:573-587.
45. Osmond C. Using age, period and cohort models to estimate future mortality rates. Int J Epidemiol. 1985;14:124-129.
46. Clements MS, Armstrong BK, Moolgavkar SH. Lung cancer rate predictions using generalized additive models. Biostatistics. 2005;6:576-589.
47. Clèries R, Martínez JM, Escribà JM, et al. Monitoring the decreasing trend of testicular cancer mortality in Spain during 2005-2019 through a Bayesian approach. Cancer Epidemiol. 2010;34:244-256.